HCAT Health Catalyst, Inc - Common stock

NASDAQ · Health Care · Ver en SEC EDGAR ↗
$1,26
Precio · May 20, 2026
Fundamentales a fecha de May 11, 2026

HCAT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$1.26
Capitalización Bursátil
P/E (TTM)
-0.9
BPA (TTM)
$-2.55
Ingresos (TTM)
$311M
Rendimiento div.
ROE
Deuda/Capital
Rango 52S
$1 – $4

HCAT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $311M
9-point trend, +325.7%
2017-12-31 2025-12-31
BPA $-2.55
7-point trend, +80.2%
2019-12-31 2025-12-31
Flujo de caja libre
4-point trend, -8.3%
2019-12-31 2022-12-31
Márgenes

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
HCAT
Mediana de Pares
P/E (TTM)
5-point trend, +92.4%
-0.9
23.2

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
HCAT
Mediana de Pares

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
HCAT
Mediana de Pares

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
HCAT
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5-point trend, +28.6%
1.5%
Revenue CAGR 3Y (Ingresos CAGR 3A)
5-point trend, +28.6%
4.0%
Revenue CAGR 5Y (Ingresos CAGR 5A)
5-point trend, +28.6%
10.5%

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
HCAT
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
5-point trend, +21.1%
$-2.55

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
HCAT
Mediana de Pares

HCAT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 15 analistas
  • Compra fuerte 3 20,0%
  • Compra 4 26,7%
  • Mantener 8 53,3%
  • Venta 0 0,0%
  • Venta fuerte 0 0,0%

Precio objetivo a 12 meses

6 analistas · 2026-05-18
Objetivo mediano $1.88 +48,8%
Objetivo medio $1.75 +38,9%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.00%
Período EPS Actual EPS est. Sorpresa
31 de marzo de 2026 $0.02 $0.02 0.00%
31 de diciembre de 2025 $0.08 $0.09 -0.01%
30 de septiembre de 2025 $0.06 $0.06 -0.00%
30 de junio de 2025 $0.04 $0.03 0.01%
31 de marzo de 2025 $0.01 $0.00 0.01%

Comparación con pares Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
HCAT -0.9 1.5%
AMWL $81M -0.8 -2.0% -38.4% -35.4%
DH -2.2 -4.2% -57.5% -28.2% 75.9%
CCLD
OPRX $230M 45.4 18.8% 4.7% 4.2% 67.2%
DRIO $79M 1.1 -17.3% -186.6% -63.2% 56.6%
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 13
Datos anuales de Estado de resultados para HCAT
Métrica Tendencia 20252024202320222021202020192018
Revenue 8-point trend, +176.4% $311M $307M $296M $276M $242M $189M $155M $113M
R&D Expense 8-point trend, +29.0% $50M $58M $73M $76M $63M $54M $46M $39M
SG&A Expense 8-point trend, +118.4% $50M $57M $77M $62M $86M $59M $32M $23M
Operating Expenses 8-point trend, +177.0% $313M $211M $259M $273M $261M $187M $134M $113M
Operating Income 8-point trend, -167.7% $-161M $-70M $-127M $-140M $-144M $-96M $-55M $-60M
Pretax Income 3-point trend, -50.5% $-177M $-69M $-118M · · · · ·
Income Tax 8-point trend, +630.4% $716.0K $333.0K $356.0K $-4M $-7M $-1M $142.0K $-135.0K
Net Income 8-point trend, -187.1% $-178M $-70M $-118M $-137M $-153M $-115M $-60M $-62M
EPS (Basic) 7-point trend, +80.2% $-2.55 $-1.15 $-2.09 $-2.56 $-3.23 $-2.91 $-12.86 ·
EPS (Diluted) 7-point trend, +80.2% $-2.55 $-1.15 $-2.09 $-2.63 $-3.23 $-2.91 $-12.86 ·
Shares (Basic) 7-point trend, +273.0% 69,896,000 60,185,000 56,418,000 53,722,000 47,495,000 39,541,000 18,741,000 ·
Shares (Diluted) 7-point trend, +273.0% 69,896,000 60,185,000 56,418,000 54,080,000 47,495,000 39,541,000 18,741,000 ·
EBITDA 4-point trend, -155.2% · · · $-140M $-144M $-96M $-55M ·
Balance general 26
Datos anuales de Balance general para HCAT
Métrica Tendencia 20252024202320222021202020192018
Cash & Equivalents 8-point trend, +78.7% $51M $250M $106M $116M $193M $92M $18M $28M
Short-term Investments 8-point trend, +843.5% $45M $142M $211M $247M $252M $179M $210M $5M
Receivables 8-point trend, +113.5% $59M $57M $60M $48M $49M $48M $28M $28M
Prepaid Expense 8-point trend, +171.5% $14M $16M $15M $16M $15M $11M $8M $5M
Current Assets 8-point trend, +153.2% $169M $466M $393M $428M $508M $330M $264M $67M
PP&E (Net) 8-point trend, +623.7% $34M $29M $26M $26M $23M $13M $4M $5M
PP&E (Gross) 8-point trend, +604.6% $87M $69M $53M $43M $35M $23M $14M $12M
Accum. Depreciation 8-point trend, +593.1% $53M $39M $27M $17M $11M $10M $10M $8M
Goodwill 8-point trend, +5559.8% $209M $260M $191M $186M $170M $108M $4M $4M
Intangibles 8-point trend, +174.4% $78M $86M $73M $92M $105M $99M $26M $28M
Other Non-current Assets 8-point trend, +455.7% $6M $6M $5M $4M $4M $4M $810.0K $1M
Total Assets 8-point trend, +352.9% $503M $859M $702M $752M $832M $578M $302M $111M
Accounts Payable 8-point trend, +416.7% $9M $11M $7M $4M $5M $5M $4M $2M
Current Liabilities 8-point trend, +114.3% $90M $326M $89M $83M $93M $88M $48M $42M
Capital Leases 8-point trend, +236.0% $14M $16M $18M $18M $20M $24M $2M $4M
Other Non-current Liabilities 8-point trend, +798000.00 $798.0K $154.0K $74.0K $121.0K $113.0K $2M $326.0K $0
Total Liabilities 8-point trend, +238.4% $257M $494M $335M $327M $310M $302M $102M $76M
Long-term Debt 5-point trend, +662.4% $153M $382M $228M · · · $48M $20M
Total Debt 4-point trend, +370.0% · · · $227M $181M $169M $48M ·
Common Stock 4-point trend, +960.0% · · · · $53.0K $43.0K $37.0K $5.0K
Paid-in Capital 4-point trend, +1400972000.00 · · · · $1.40B $1.00B $811M $0
Retained Earnings 8-point trend, -264.1% $-1.36B $-1.19B $-1.12B $-999M $-879M $-726M $-611M $-375M
AOCI 8-point trend, +158700.0% $2M $-835.0K $33.0K $-648.0K $-67.0K $61.0K $72.0K $-1.0K
Stockholders' Equity 8-point trend, +165.6% $246M $365M $367M $425M $522M $276M $201M $-375M
Liabilities + Equity 8-point trend, +352.9% $503M $859M $702M $752M $832M $578M $302M $111M
Shares Outstanding 8-point trend, +1407.1% 72,027,332 64,043,799 58,295,491 55,261,922 52,622,080 43,376,848 36,678,854 4,779,356
Flujo de Efectivo 15
Datos anuales de Flujo de Efectivo para HCAT
Métrica Tendencia 20252024202320222021202020192018
D&A 8-point trend, +581.3% $50M $41M $42M $48M $38M $19M $9M $7M
Stock-based Comp 8-point trend, +543.4% $27M $40M $56M $72M $65M $38M $18M $4M
Deferred Tax 8-point trend, +149.7% $81.0K $77.0K $8.0K $-5M $-7M $-1M $40.0K $-163.0K
Amort. of Intangibles 8-point trend, +596.1% $36M $29M $30M $37M $32M $16M $6M $5M
Operating Cash Flow 8-point trend, +101.8% $731.0K $15M $-33M $-35M $-23M $-26M $-32M $-40M
CapEx 8-point trend, -53.4% $968.0K $2M $1M $2M $10M $8M $2M $2M
Investing Cash Flow 8-point trend, +69.1% $36M $-23M $20M $-39M $-140M $-83M $-210M $21M
Debt Issued 3-point trend, +0.00 $0 $152M $0 · · · · ·
Stock Issued 5-point trend, -100.0% · · $0 $0 $245M $0 $195M ·
Stock Repurchased 8-point trend, -42.6% $5M $0 $2M $8M $0 $0 $0 $9M
Net Stock Activity 4-point trend, -8393000.00 · · · $-8M $245M $0 $0 ·
Financing Cash Flow 8-point trend, -1068.5% $-236M $152M $3M $-3M $264M $183M $231M $24M
Net Change in Cash 8-point trend, -3746.3% $-199M $143M $-10M $-77M $101M $74M $-10M $5M
Taxes Paid $395.0K · · · · · · ·
Free Cash Flow 4-point trend, -8.3% · · · $-37M $-34M $-34M $-35M ·
Rentabilidad 5
Datos anuales de Rentabilidad para HCAT
Métrica Tendencia 20252024202320222021202020192018
Operating Margin 4-point trend, -43.1% · · · -50.7% -59.4% -50.9% -35.4% ·
Net Margin 4-point trend, -28.2% · · · -49.7% -63.3% -60.9% -38.8% ·
EBITDA Margin 4-point trend, -43.1% · · · -50.7% -59.4% -50.9% -35.4% ·
ROA 4-point trend, +40.4% · · · -17.3% -21.7% -26.1% -29.1% ·
ROE 4-point trend, -7.6% · · · -31.8% -28.6% -40.0% -29.5% ·
Liquidez y Solvencia 4
Datos anuales de Liquidez y Solvencia para HCAT
Métrica Tendencia 20252024202320222021202020192018
Current Ratio 4-point trend, -5.4% · · · 5.2 5.5 3.7 5.5 ·
Quick Ratio 4-point trend, -6.0% · · · 5.0 5.3 3.6 5.3 ·
Debt / Equity 4-point trend, +121.9% · · · 0.5 0.3 0.6 0.2 ·
LT Debt / Equity 4-point trend, +121.9% · · · 0.5 0.3 0.6 0.2 ·
Eficiencia 2
Datos anuales de Eficiencia para HCAT
Métrica Tendencia 20252024202320222021202020192018
Asset Turnover 4-point trend, -53.5% · · · 0.3 0.3 0.4 0.7 ·
Receivables Turnover 4-point trend, +1.8% · · · 5.7 5.0 5.0 5.6 ·
Por Acción 5
Datos anuales de Por Acción para HCAT
Métrica Tendencia 20252024202320222021202020192018
Book Value / Share 3-point trend, +20.8% · · · $7.69 $9.92 $6.37 · ·
Revenue / Share 2-point trend, +0.3% · · · $5.11 $5.09 · · ·
Cash Flow / Share 2-point trend, -33.9% · · · $-0.65 $-0.49 · · ·
Cash / Share 3-point trend, -0.7% · · · $2.10 $3.67 $2.12 · ·
EPS (TTM) 7-point trend, +80.2% $-2.55 $-1.15 $-2.09 $-2.63 $-3.23 $-2.91 $-12.86 ·
Tasas de Crecimiento 3
Datos anuales de Tasas de Crecimiento para HCAT
Métrica Tendencia 20252024202320222021202020192018
Revenue YoY 5-point trend, -94.7% 1.5% 3.6% 7.1% 14.2% 28.1% · · ·
Revenue CAGR 3Y 3-point trend, -74.9% 4.0% 8.2% 16.2% · · · · ·
Revenue CAGR 5Y 10.5% · · · · · · ·
Valoración (TTM) 14
Datos anuales de Valoración (TTM) para HCAT
Métrica Tendencia 20252024202320222021202020192018
Revenue TTM 7-point trend, +100.8% $311M $307M $296M $276M $242M $189M $155M ·
Net Income TTM 7-point trend, -196.1% $-178M $-70M $-118M $-137M $-153M $-115M $-60M ·
Market Cap 3-point trend, -68.9% · · · $587M $2.08B $1.89B · ·
Enterprise Value 3-point trend, -74.8% · · · $450M $1.82B $1.79B · ·
P/E 7-point trend, +65.3% -0.9 -6.1 -4.4 -4.0 -12.3 -15.0 -2.7 ·
P/S 3-point trend, -78.7% · · · 2.1 8.6 10.0 · ·
P/B 3-point trend, -79.8% · · · 1.4 4.0 6.8 · ·
P / Tangible Book 5-point trend, -14.3% · 23.3 5.2 4.0 8.4 27.2 · ·
P / Cash Flow 3-point trend, +76.9% · · · -16.7 -90.2 -72.2 · ·
P / FCF 3-point trend, +71.8% · · · -15.7 -62.1 -55.7 · ·
EV / EBITDA 3-point trend, +82.7% · · · -3.2 -12.7 -18.6 · ·
EV / FCF 3-point trend, +77.1% · · · -12.0 -54.2 -52.7 · ·
EV / Revenue 3-point trend, -82.8% · · · 1.6 7.5 9.5 · ·
Earnings Yield 7-point trend, -187.9% -106.7% -16.3% -22.6% -24.7% -8.2% -6.7% -37.1% ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $311M$307M$296M$276M$242M
Margen Operativo % -50.7%-59.4%
Beneficio neto $-178M$-70M$-118M$-137M$-153M
EPS Diluido $-2.55$-1.15$-2.09$-2.63$-3.23
Balance general
2025-12-312024-12-312023-12-312022-12-312021-12-31
Deuda / Patrimonio 0.50.3
Ratio corriente 5.25.5
Ratio Rápido 5.05.3
Flujo de Efectivo
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flujo de caja libre $-37M$-34M

Últimas noticias Noticias recientes que mencionan a esta empresa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.